Prostate biopsy concordance in a large population-based sample: a Surveillance, Epidemiology and End Results study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prostate biopsy concordance in a large population-based sample: a Surveillance, Epidemiology and End Results study
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PATHOLOGY
Volume 68, Issue 6, Pages 453-457
Publisher
BMJ
Online
2015-03-12
DOI
10.1136/jclinpath-2014-202767
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3 + 4 prostate cancer
- (2014) Tatsuo Gondo et al. BJU INTERNATIONAL
- Concordance between transrectal ultrasound guided biopsy results and radical prostatectomy final pathology: Are we getting better at predicting final pathology?
- (2014) Richard Walker et al. CUAJ-Canadian Urological Association Journal
- Predictors of Gleason score upgrading in patients with prostate biopsy Gleason score ≤6
- (2014) Hasmet Sarici et al. CUAJ-Canadian Urological Association Journal
- Downgrading of biopsy based Gleason score in prostatectomy specimens
- (2014) Kilian M Treurniet et al. JOURNAL OF CLINICAL PATHOLOGY
- Upgrading of Gleason score and prostate volume: a clinicopathological analysis
- (2013) Kwang Hyun Kim et al. BJU INTERNATIONAL
- Concordance Between Prostate Needle Biopsy and Surgical Histopathology in a Primarily African-American Population
- (2013) Manuj Agarwal et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- How significant is upgrade in Gleason score between prostate biopsy and radical prostatectomy pathology while discussing less invasive treatment options?
- (2013) Evren Suer et al. Scandinavian Journal of Urology
- Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades
- (2012) Jonathan I. Epstein et al. EUROPEAN UROLOGY
- The novel nomogram of Gleason sum upgrade: Possible application for the eligible criteria of low dose rate brachytherapy
- (2010) Lars Budäus et al. INTERNATIONAL JOURNAL OF UROLOGY
- Gleason Score Correlation Between Biopsy and Prostatectomy Specimens and Prediction of High-grade Gleason Patterns: Significance of Central Pathologic Review
- (2010) Kentaro Kuroiwa et al. UROLOGY
- A nomogram for predicting upgrading in patients with low- and intermediate-grade prostate cancer in the era of extended prostate sampling
- (2009) Ayman S. Moussa et al. BJU INTERNATIONAL
- Prostate Specific Antigen Density to Predict Prostate Cancer Upgrading in a Contemporary Radical Prostatectomy Series: A Single Center Experience
- (2009) Ahmed Magheli et al. JOURNAL OF UROLOGY
- Upgrading of Gleason score 6 prostate cancers on biopsy after prostatectomy in the low and intermediate tPSA range
- (2009) D Colleselli et al. PROSTATE CANCER AND PROSTATIC DISEASES
- External Validation of a Nomogram Predicting the Probability of Prostate Cancer Gleason Sum Upgrading Between Biopsy and Radical Prostatectomy Pathology Among Japanese Patients
- (2009) Takashi Imamoto et al. UROLOGY
- Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer
- (2008) Ayman S. Moussa et al. BJU INTERNATIONAL
- Prostate Cancer Volume at Biopsy Predicts Clinically Significant Upgrading
- (2008) Fei Dong et al. JOURNAL OF UROLOGY
- Patient risk stratification using Gleason score concordance and upgrading among men with prostate biopsy Gleason score 6 or 7
- (2008) Faye B. Serkin et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started